Cargando…

Improving ultrasound-based prostate volume estimation

BACKGROUND: To define a new coefficient to be used in the formula (Volume = L x H x W x Coefficient) that better estimates prostate volume using dimensions of fresh prostates from patients who had transrectal ultrasound (TRUS) imaging prior to prostatectomy. METHODS: The prostate was obtained from 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aprikian, Saro, Luz, Murilo, Brimo, Fadi, Scarlata, Eleonora, Hamel, Lucie, Cury, Fabio L., Tanguay, Simon, Aprikian, Armen G., Kassouf, Wassim, Chevalier, Simone
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6657110/ https://www.ncbi.nlm.nih.gov/pubmed/31340802 http://dx.doi.org/10.1186/s12894-019-0492-2

Ejemplares similares

Changes in the outcome of prostate biopsies after preventive task force recommendation against prostate-specific antigen screening
por: Zakaria, Ahmed S., et al.
Publicado: (2018)

Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor
por: Luz, Murilo A, et al.
Publicado: (2010)

Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression
por: Derderian, Seta, et al.
Publicado: (2023)

Aldehyde dehydrogenase 1 expression in primary and metastatic renal cell carcinoma: an immunohistochemistry study
por: Abourbih, Samuel, et al.
Publicado: (2013)

Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study
por: Florianova, Livia, et al.
Publicado: (2015)

Phase I Clinical Trial of Everolimus Combined with Trimodality Therapy in Patients with Muscle-Invasive Bladder Cancer
por: Bachir, Bassel G., et al.
Publicado: (2017)

Asporin is a stromally expressed marker associated with prostate cancer progression
por: Rochette, Annie, et al.
Publicado: (2017)

PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity
por: Choucair, Khalil, et al.
Publicado: (2012)

Role of Serum Lymphocyte-derived Biomarkers in Nonmetastatic Muscle-invasive Bladder Cancer Patients Treated with Trimodal Therapy
por: Kool, Ronald, et al.
Publicado: (2021)

Clinical Management and Burden of Prostate Cancer: A Markov Monte Carlo Model
por: Sanyal, Chiranjeev, et al.
Publicado: (2014)

Nuclear mTOR acts as a transcriptional integrator of the androgen signaling pathway in prostate cancer
por: Audet-Walsh, Étienne, et al.
Publicado: (2017)

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance
por: Kotb, A F, et al.
Publicado: (2011)

The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases
por: Chevalier, Simone, et al.
Publicado: (2015)

Chronic prednisone, metformin, and nonsteroidal anti-inflammatory drug use and clinical outcome in a cohort of bladder cancer patients undergoing radical cystectomy in Québec, Canada
por: Wissing, Michel D., et al.
Publicado: (2023)

Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada
por: Santos, Fabiano, et al.
Publicado: (2015)

Drug costs in the management of metastatic castration-resistant prostate cancer in Canada
por: Dragomir, Alice, et al.
Publicado: (2014)

Early detection of clinically significant prostate cancer at diagnosis: a prospective study using a novel panel of TMPRSS2:ETS fusion gene markers
por: Chan, Sam W., et al.
Publicado: (2013)

Liquid biopsy‐based targeted gene screening highlights tumor cell subtypes in patients with advanced prostate cancer
por: Derderian, Seta, et al.
Publicado: (2022)

Simultaneous Quantification of Mitochondrial DNA Damage and Copy Number in Circulating Blood: A Sensitive Approach to Systemic Oxidative Stress
por: Chan, Sam W., et al.
Publicado: (2013)

Combining mTOR Inhibition with Radiation Improves Antitumor Activity in Bladder Cancer Cells In Vitro and In Vivo: A Novel Strategy for Treatment
por: Nassim, Roland, et al.
Publicado: (2013)

Leukobiopsy – A Possible New Liquid Biopsy Platform for Detecting Oncogenic Mutations
por: Chennakrishnaiah, Shilpa, et al.
Publicado: (2020)

Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec
por: Hu, Jason, et al.
Publicado: (2022)

Impact of Programmed Death-ligand 1 Expression on Oncological Outcomes in Patients with Muscle-invasive Bladder Cancer Treated with Radiation-based Therapy
por: Marcq, Gautier, et al.
Publicado: (2022)

Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
por: Mahmud, S, et al.
Publicado: (2004)

Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer
por: Rouleau, Michèle, et al.
Publicado: (2022)

The Health Economics of Metastatic Hormone-Sensitive and Non-Metastatic Castration-Resistant Prostate Cancer—A Systematic Literature Review with Application to the Canadian Context
por: Yanev, Ivan, et al.
Publicado: (2022)

Ciprofloxacin Alone vs. Ciprofloxacin plus an Aminoglycoside for the Prevention of Infectious Complications following a Transrectal Ultrasound-Guided Prostate Biopsy: A Retrospective Cohort Study
por: Thirion, Daniel J. G., et al.
Publicado: (2022)

The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation
por: Ouellet, Véronique, et al.
Publicado: (2018)

Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada
por: Blanc-Lapierre, Audrey, et al.
Publicado: (2015)

Adherence to oral hormonal therapy in advanced prostate cancer: a scoping review
por: Fleshner, Neil E., et al.
Publicado: (2023)

Robotic-assisted radical nephrectomy for renal angiomyolipoma with inferior vena cava thrombus extension
por: Alrabeeah, Khalid A., et al.
Publicado: (2014)

Differences in prostate cancer detection between Canadian and Saudi populations
por: Al-Abdin, O.Z., et al.
Publicado: (2013)

Feasibility and Impact of Immunohistochemistry-based Molecular Subtyping for Muscle-invasive Bladder Cancer in Patients Treated with Radiation-based Therapy
por: Hesswani, Charles, et al.
Publicado: (2023)

Clinical analysis of EV‐Fingerprint to predict grade group 3 and above prostate cancer and avoid prostate biopsy
por: Fairey, Adrian, et al.
Publicado: (2023)

Presence of lymphocytic infiltrate cytotoxic T lymphocyte CD3(+), CD8(+), and immunoscore as prognostic marker in patients after radical cystectomy
por: Yu, Alice, et al.
Publicado: (2018)

Mitosis Phase Enrichment with Identification of Mitotic Centromere-Associated Kinesin As a Therapeutic Target in Castration-Resistant Prostate Cancer
por: Sircar, Kanishka, et al.
Publicado: (2012)

Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A Population-Based Nested Case-Control Study
por: Mahmud, Salaheddin M., et al.
Publicado: (2011)

Role of neutrophil extracellular traps in radiation resistance of invasive bladder cancer
por: Shinde-Jadhav, Surashri, et al.
Publicado: (2021)

Combined radiotherapy and immunotherapy in urothelial bladder cancer: harnessing the full potential of the anti-tumor immune response
por: Daro-Faye, Mame, et al.
Publicado: (2020)

Erectile function after partial penectomy for penile cancer
por: Monteiro, Leonardo L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7bbau6ca0k5e5fgntu6877v8nk